Description
Mechanism
N-terminal trans-3-hexenoyl GHRH(1-44). clinically validated for visceral adipose reduction.
Research applications
- Visceral fat research
- Lipodystrophy models
Specifications
- Purity: 99.5% (HPLC / MS verified)
- Vial size: 2mg
- Available sizes: 2mg, 5mg, 10mg
- Form: Lyophilized powder
- Storage: -20°C, protect from light
For laboratory research use only. Not for human or veterinary use. Lot-matched Certificate of Analysis included with every order.
Reviews
There are no reviews yet.